Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,580,860
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
7,553,417
-
Shares change
-
+913,991
-
Total reported value, excl. options
-
$109,372,908
-
Value change
-
+$12,894,624
-
Put/Call ratio
-
350%
-
Number of buys
-
37
-
Number of sells
-
-20
-
Price
-
$14.48
Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q3 2019
72 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q3 2019.
OptimizeRx Corp - Common Stock (OPRX) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,553,417 shares
of 18,580,860 outstanding shares and own 41% of the company stock.
Largest 10 shareholders include Park West Asset Management LLC (1,079,136 shares), BlackRock Inc. (775,515 shares), G2 Investment Partners Management LLC (664,106 shares), WOLVERINE ASSET MANAGEMENT LLC (651,222 shares), VANGUARD GROUP INC (589,117 shares), WASATCH ADVISORS INC (387,292 shares), CALAMOS ADVISORS LLC (312,764 shares), 1492 Capital Management LLC (235,229 shares), STATE STREET CORP (231,665 shares), and AVENIR CORP (224,100 shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.